Resource Logo

The lung in the immunocompromised patient. Infectious complications part 2.


Unique Identifier : AIDSLINE MED/99294838

Pulmonary infections decisively contribute to morbidity and mortality in immunocompromised patients. Bacterial, mycobacterial and infections with Pneumocystis carinii have been reviewed in an article in the last issue of Respiration. In this review, viral and fungal pulmonary infections are discussed in HIV-positive patients and in patients treated with high-dose chemotherapy, stem cell or solid-organ transplantation.

JOURNAL ARTICLE REVIEW REVIEW, TUTORIAL Drug Therapy/ADVERSE EFFECTS Human HIV Seropositivity/COMPLICATIONS Immunocompromised Host/*PHYSIOLOGY Lung Diseases/*ETIOLOGY Mycoses/*ETIOLOGY Organ Transplantation Postoperative Complications Stem Cells/TRANSPLANTATION Virus Diseases/*ETIOLOGY


Information in this article was accurate in November 30, 1999. The state of the art may have changed since the publication date. This material is designed to support, not replace, the relationship that exists between you and your doctor. Always discuss treatment options with a doctor who specializes in treating HIV.